Try our beta test site
1 study found for:    9050879 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer
Conditions: Metastatic Cancer;   Metastatic Melanoma;   Metastatic Renal Cancer
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Other: IL-12 & Anti-NY ESO1 TCR PBL

Study has passed its completion date and status has not been verified in more than two years.